0001104659-23-026776.txt : 20230228 0001104659-23-026776.hdr.sgml : 20230228 20230228165047 ACCESSION NUMBER: 0001104659-23-026776 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230228 DATE AS OF CHANGE: 20230228 EFFECTIVENESS DATE: 20230228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GMO TRUST CENTRAL INDEX KEY: 0000772129 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 002-98772 FILM NUMBER: 23686633 BUSINESS ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6173467646 MAIL ADDRESS: STREET 1: 40 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: GMO CORE TRUST DATE OF NAME CHANGE: 19900927 0000772129 S000077554 GMO Small Cap Quality Fund C000238037 Class R6 C000238038 Class IV C000238039 Class I GMAYX C000238040 Class V C000238041 Class III GMAWX C000238042 Class VI GSBGX 497 1 tm237919d3_497.htm 497

 

Filed pursuant to Rule 497(e)

File Nos. 002-98772 and 811-04347

 

GMO TRUST

 

Supplement dated February 28, 2023, to the
GMO Trust Statement of Additional Information relating to Small Cap Quality Fund, dated September 20, 2022

 

Following the resignation of Carolyn Haley, Dina Santoro has been elected as a Trustee and President of GMO Trust by the GMO Trust Board of Trustees.

 

The following “Interested Trustee and Officer” section is added to the table on page 90 of the SAI:

 

Name and
Year of Birth		   Position(s)
Held
with the
Trust		   Length of
Time Served		   Principal Occupation(s)
During Past 5 Years*		   Number
of
Portfolios
in Fund
Complex1
Overseen		   Other
Directorships
Held in the
Past Five
Years
INDEPENDENT TRUSTEES
Donald W. Glazer
YOB: 1944 		  Chairman of the Board of Trustees   Chairman of the Board of Trustees since March 2005; Lead Independent Trustee (September 2004-March 2005); Trustee since December 2000.   Consultant – Law and Business; Author of Legal Treatises.   33   Director, BeiGene Ltd.(biotech).
Peter Tufano
YOB: 1957		   Trustee   Since December 2008.   Peter Moores Professor of Finance (Since July 1, 2011) and Peter Moores Dean and Professor of Finance (July 1, 2011 – June 30, 2021) University of Oxford, Said Business School.   33   None
Paul Braverman
YOB: 1949		   Trustee   Since March 2010.   Retired.   33   Trustee of HIMCO Variable Insurance Trust (27 Portfolios) (April 2014-April 2019).
INTERESTED TRUSTEE AND OFFICER

Dina Santoro2

YOB: 1973

   Trustee; President of the Trust   Trustee and President since February 2023.  

Chief Operating Officer, Grantham, Mayo, Van Otterloo & Co. LLC (February 2023 – Present); President, Chief Executive Officer, and Director, Voya Investments, LLC, Voya Capital, LLC, and Voya Funds Services, LLC

(September 2022 – December 2022); Director and Senior Vice President, Voya Investments Distributor, LLC

(April 2018 –December 2022); Chief Operating Officer, Voya Investment Management (January 2022 –December 2022); Senior Managing Director, Head of Product and Marketing Strategy, Voya Investment Management (September 2017-December 2022). Formerly, President and Director, Voya Investments, LLC and Voya Capital, LLC (March 2018-September 2022); Director, Voya Funds Services, LLC (March 2018-September 2022).

   33   Voya Separate Portfolios Trust (July 2018 – December 2022)
                       

1The Fund Complex includes series of each of GMO Trust.

2 Ms. Santoro is an “interested person” of the Trust, as such term is used in the 1940 Act (an “Interested Trustee”), by virtue of her positions with the Trust and GMO indicated in the table above and her interest as a member of GMO.

 

 

 

 

The following description of the attributes of the Interested Trustee considered by the Governance Committee is added to page 91 of the SAI following the description of the attributes of the Independent Trustee:

 

Interested Trustee

 

Dina Santoro — Ms. Santoro’s experience as a senior executive in the asset management industry, including her service as a mutual fund director and chief executive officer, her professional training and experience in business and finance, as well as her perspective on Board matters as a senior executive of GMO.

 

The following is added as the first row of the table entitled “Officers” in the “Management of the Trust” section on page 91 of the SAI:

 

Name and Year of Birth  Position(s) Held
with the Trust		  Length
of Time Served		  Principal Occupation(s)
During Past 5 Years*
Dina Santoro
 
YOB: 1973		  Trustee; President of the Trust  Trustee and President since February 2023  Chief Operating Officer, Grantham, Mayo, Van Otterloo & Co. LLC (February 2023 – Present); President, Chief Executive Officer, and Director, Voya Investments, LLC, Voya Capital, LLC, and Voya Funds Services, LLC (September 2022 – December 2022); Director and Senior Vice President, Voya Investments Distributor, LLC
(April 2018 –December 2022); Chief Operating Officer, Voya Investment Management (January 2022 –December 2022); Senior Managing Director, Head of Product and Marketing Strategy, Voya Investment Management (September 2017-December 2022). Formerly, President and Director, Voya Investments, LLC and Voya Capital, LLC (March 2018-September 2022); Director, Voya Funds Services, LLC (March 2018-September 2022).

 

The following are added as “Interested Trustee” subsections of the “Trustee Fund Ownership” tables on pages 95 and 96 of the SAI:

 

Name/Funds Dollar Range of
Shares Directly Owned in
the Funds 		Aggregate Dollar Range of Shares Directly Owned in all Registered Investment Companies (whether or not offered in the Prospectus) Overseen by Trustee in Family of Investment Companies
INTERESTED TRUSTEE
Dina Santoro None None

 

Name/Funds Dollar Range of
Shares Indirectly Owned in
the Funds 		Aggregate Dollar Range of Shares Indirectly Owned in all Registered Investment Companies (whether or not offered in the Prospectus) Overseen by Trustee in Family of Investment Companies
INTERESTED TRUSTEE
Dina Santoro None None

 

The first sentence of the second paragraph on page 98 of the SAI is deleted and replaced with the following.

 

Ms. Santoro does not receive any compensation from the Fund Complex.

 

All other references to “Carolyn Haley” are replaced with references to “Dina Santoro”.

 

INVESTORS SHOULD RETAIN THIS SUPPLEMENT FOR FUTURE REFERENCE

 

2